ARCHIVES

Beth Israel Suspends Enrollment In Trials Following An Audit

This article is from The Cancer Letter archive.

Vol. 36 No. 38 | October 22, 2010

Download PDF Visit The Full Archive

Related Articles

NIH Director Varmus Names President of Sloan-Kettering, Succeeding Mark

October 15, 1999

ECOG Subcontractors Critique Cancer Control Program

August 24, 1979

Dendritic Cell Vaccine May Boost Median Survival

March 25, 2011

Cancer Meetings Listed

March 26, 1993

Bush Asks Hammer To Probe FDA Regulation Of Anticancer Drugs

June 17, 1988

Proceedings Initiated Against Two Physicians At Dana-Farber

April 7, 1995